Delivery Order SPE2DB22D9112-SPE2DB24FE6XT

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 contract is for the delivery of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 order is for 60 tablets of the prescription drug XTANDI 80 MG. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 contract is for the delivery of XTANDI 80 MG TABLET 60S, a prescription medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) the DLA has with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 contract is to provide 120 capsules of the medication XTANDI 40 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 order was placed by the Defense Logistics Agency (DLA) under the SPE2DB program, which is a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. The delivery order is for 4564389513 XTANDI 40 MG CAPSULE 120S, a specialty pharmaceutical product. DMS...
This is a firm fixed-price delivery order under contract SPE2DB24D9144 awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 contract is for the delivery of 120 capsules of the prescription drug XTANDI 40 mg to the Defense Logistics Agency (DLA), a defense agency. The order has a completion date of June 7, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract with the DLA for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an award ceiling value of $8,622.70, is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,169.59, is for the delivery of XTANDI 40 MG TABLET 120S. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $8,622.72, is for the supply of XTANDI 40 MG CAPSULE 120S for the federal government. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 order is for 120 capsules of the prescription drug XTANDI 40 MG. The order is part of a larger $499,999,999 indefinite-delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FE6XT
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 contract was awarded by the Defense Logistics Agency (DLA) to provide 120 tablets of the medication XTANDI 40 MG.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to supply a wide range of pharmaceutical products, including both common medications and specialized drugs, to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order represents a call against that broader IDC vehicle. The contract has no set-aside designation.

Generated 12/12/24, 10:02 AM